UnitedHealth Group Incorporated $UNH Shares Sold by Security National Bank

Security National Bank cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 94.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 368 shares of the healthcare conglomerate’s stock after selling 5,845 shares during the period. Security National Bank’s holdings in UnitedHealth Group were worth $127,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of UNH. LFA Lugano Financial Advisors SA purchased a new position in shares of UnitedHealth Group in the second quarter worth approximately $25,000. Bayforest Capital Ltd grew its position in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares in the last quarter. Sagard Holdings Management Inc. purchased a new stake in shares of UnitedHealth Group in the second quarter valued at $29,000. Islay Capital Management LLC purchased a new position in shares of UnitedHealth Group during the second quarter valued at $31,000. Finally, Riggs Asset Managment Co. Inc. lifted its stake in UnitedHealth Group by 69.4% in the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 43 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH opened at $332.13 on Wednesday. The stock has a 50-day moving average of $332.33 and a 200-day moving average of $319.37. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $606.36. The company has a market cap of $300.86 billion, a PE ratio of 17.33, a price-to-earnings-growth ratio of 2.14 and a beta of 0.43.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same quarter in the prior year, the business earned $7.15 earnings per share. The company’s revenue was up 12.2% on a year-over-year basis. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date was Monday, December 8th. UnitedHealth Group’s dividend payout ratio is 46.14%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on UNH. Zacks Research upgraded UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Wells Fargo & Company increased their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Leerink Partners set a $410.00 price target on shares of UnitedHealth Group and gave the company an “outperform” rating in a report on Wednesday, October 29th. JPMorgan Chase & Co. lifted their price objective on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Finally, Deutsche Bank Aktiengesellschaft downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target for the company. in a research note on Wednesday, October 29th. Seventeen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Hold” and a consensus target price of $385.54.

Read Our Latest Analysis on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.